IL15 and type 1 diabetes mellitus: Importantly, an anti-CD132 monoclonal antibody (anti-CD132) or an anti-IL-15 monoclonal antibody (anti- IL-15) prevented the onset of T1D and improved its condition as prophylactic administration in nondiabetic non-obese diabetic (NOD) mice.